Regulation of the HIF-1 activity is complex and partly O2-independent via RACK-1 protein, a mechanism, that is important in cancer therapy and in the effect of the immunosuppressive drug cyclosporine A (Semenza, 2009). The gene discussed is HIF1A; the disease is cancer.